Topic

Peptides for energy and mitochondrial health

Almost every cell in your body runs on fuel made by mitochondria, and how well they work shapes how you feel day to day. This topic covers peptides for energy and the molecules behind it — NAD, which cells use to move energy around, and mitochondrial peptides like MOTS-c and SS-31.

The articles explain the science the way you'd want a friend to: what these compounds are, what studies show, and what's still unproven. All are prescription-only through a licensed provider.

38 articles on this topic

  1. A woman sits on the front steps of a house beside a basket of apples

    Where to Inject MOTS-c: What the Evidence Says

    The available human trial records point to a subcutaneous shot into the fatty layer beneath the skin. The pharmacy label and prescriber—not an online injection map—set the site for a specific MOTS-c preparation.

    September 15, 2026 · Elena Marsh, Health Writer
  2. A woman sits in an armchair by a bright windowsill holding a plain ceramic mug

    SS-31 Protocol: What the Trials Actually Used

    There is no single SS-31 cycle supported by human research. The useful evidence is narrower: a labeled plan for one rare disease and several trial schedules that cannot be copied into personal dosing advice.

    September 14, 2026 · Priya Raman, Health Writer
  3. A man sits cross-legged on a bare exercise mat in an empty room, facing the camera, a single potted plant behind him

    SS-31 and MOTS-c: Can You Take Them Together?

    They are both mitochondrial peptides, and that is about where the similarity stops. No published trial has given people both at once — here is what each one has behind it.

    September 12, 2026 · Nadia Okonjo, Health Writer
  4. A woman in a sage top sits on an entryway bench and laces a shoe beneath a window

    When to Take MOTS-c: What Human Research Says

    No human trial has shown that morning, night, or a workout window is best. The exercise link is real but easy to overread: researchers measured the MOTS-c people made themselves, not the effect of a timed dose.

    September 12, 2026 · Elena Marsh, Health Writer
  5. A woman in a rust-colored jacket and full-length dark trousers walks toward the camera along a wooded path

    MOTS-c Cycle: Nobody Has Established One

    The word “cycle” came from bodybuilding, not from any MOTS-c research. Every study that has actually given the peptide — the mouse work, and the one human trial now running — dosed it straight through, with no weeks off.

    September 11, 2026 · Priya Raman, Health Writer
  6. A man sits on a wooden bench beneath a window, lacing a running shoe

    MOTS-c Half-Life: What Is Actually Known

    No published study has measured how long the body takes to clear a dose of MOTS-c. Here is what the rodent work, the exercise data and one unpublished Phase 1 trial actually show.

    September 9, 2026 · Priya Raman, Health Writer
  7. A woman walks toward the camera on a quiet desert trail in soft morning light

    SS-31 Benefits: What Human Trials Actually Show

    The clearest human evidence for SS-31 is narrow: muscle-strength findings in people with Barth syndrome. Larger trials in other mitochondrial, heart, and eye conditions have produced mixed or negative primary results.

    September 3, 2026 · Elena Marsh, Health Writer
  8. A woman in a sage sweater rests on a linen sofa in a quiet sunlit room

    NAD Injection Dosage: What Human Studies Used

    There is no validated subcutaneous or intramuscular NAD+ schedule. The best-known IV pharmacokinetic study used 750 mg over six hours, so a prescriber must set route, concentration, amount and frequency together.

    August 31, 2026 · Elena Marsh, Health Writer
  9. A woman in a sage shirt sits in an armchair beside a window holding a plain mug

    Is NAD a Peptide? What NAD+ Actually Is

    NAD+ is a dinucleotide coenzyme, not a peptide. Its chemistry, cellular jobs, and evidence are different from the peptide therapies it often appears beside.

    August 30, 2026 · Priya Raman, Health Writer
  10. A woman in a blue shirt and navy trousers tends a houseplant in soft morning light

    Peptides for Insulin Resistance: Evidence

    The evidence runs from large clinical trials for semaglutide and tirzepatide to animal and observational research for MOTS-c. Those are not interchangeable levels of certainty.

    August 29, 2026 · Nadia Okonjo, Health Writer
  11. A woman sits on a low sofa in a sunlit living room, holding a ceramic mug in both hands

    Does Tirzepatide Make You Tired? What Trials Say

    Fatigue was reported by 5–7% of trial participants on tirzepatide against 3% on placebo. The more useful question is what is actually causing it.

    August 27, 2026 · Elena Marsh, Health Writer
  12. A man in a long-sleeve shirt and work trousers kneels beside a raised vegetable bed in a small garden

    NAD Injection Side Effects: What Is Reported

    Published intravenous data describe transient infusion-associated symptoms in one small retrospective series and no reported adverse events in an earlier slow-infusion pilot; because the studies differed in design and did not randomize infusion rate, they do not establish speed as the cause.

    August 27, 2026 · Julian Reyes, Health Writer
  13. A woman in a full-length robe stands in a quiet spa room holding a ceramic cup

    SS-31 Peptide Dosage: What the Trials Used

    Human elamipretide studies have used multiple regimens, including weight-based intravenous infusions and, in PROGRESS-HF, 4 mg or 40 mg subcutaneously once daily; several later disease trials used 40 mg daily. Those figures are trial parameters rather than a protocol anyone can lift — Forzinity has a labeled regimen for Barth syndrome, but no established regimen exists for compounded SS-31 or wellness use.

    August 27, 2026 · Priya Raman, Health Writer
  14. A woman in a long-sleeve top and full-length leggings holds a calm seated stretch on a mat in a sunlit room

    MOTS-c Side Effects: What Is Known and What Is Not

    No completed human trial has measured them. What gets sold as a MOTS-c side-effect profile is assembled from injection-site experience with subcutaneous peptides, from pharmacology, and from what a prescriber screens for.

    August 25, 2026 · Elena Marsh, Health Writer
  15. A man performs a controlled dumbbell curl beside a window in a sunlit gym

    MOTS-c Dosage: Why There Is No Standard Dose

    There is no established human MOTS-c dose. Published human research is mostly observational, and the numbers repeated online come largely from mouse experiments rather than clinical dosing trials.

    August 17, 2026 · Priya Raman, Health Writer
  16. A person walking a small dog along a quiet tree-lined sidewalk at sunrise

    SS-31 Peptide: A Patient's Guide to Elamipretide

    SS-31 and elamipretide are two names for the same four-amino-acid peptide, and its branded injectable form received accelerated approval from the FDA on September 19, 2025 for a single ultra-rare genetic disease.

    August 13, 2026 · Julian Reyes, Health Writer
  17. A woman in a cream sweater walking a tree-lined path in morning light

    MOTS-c Peptide Benefits: Rodent Depth, Human Hints

    MOTS-c is a peptide your mitochondria encode themselves — and it is studied for how cells handle fuel. The rodent evidence runs deep; the human evidence is just beginning.

    August 9, 2026 · Nadia Okonjo, Health Writer
  18. A woman stands at a sunlit kitchen counter in the morning, holding a cup of coffee and looking out the window.

    A Patient's Guide to NAD+ Injections

    NAD+ is a coenzyme found in every living cell, yet most human trial data comes from oral precursors like NR and NMN — including a 2025 meta-analysis in adults with mean ages of 61 to 83 that found no significant muscle benefit.

    August 12, 2026 · Nadia Okonjo, Health Writer

Page 2 of 2 · 38 articles